A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.

Disclosed is a ceramic sintered shaped body containing Y.sub.2O.sub.3-stabilized zirconia with a sintered density of at least 99% of the theoretical sintered density and having a mean grain size of <180 nm. The zirconia fraction of the sintered shaped body comprises tetragonal and cubic phases. Also disclosed is a process for the production of a ceramic sintered shaped body containing Y.sub.2O.sub.3-stabilized zirconia, which process comprises dispersion of a submicron powder and comminution of the dispersed submicron powder by means of grinding media having a diameter of less than or equal to 100 μm to a particle size d.sub.95 of <0.42 μm; shaping of the dispersion to form a body, and sintering of the body to form the sintered shaped body.

Disclosed is a ceramic sintered shaped body containing Y.sub.2O.sub.3-stabilized zirconia with a sintered density of at least 99% of the theoretical sintered density and having a mean grain size of <180 nm. The zirconia fraction of the sintered shaped body comprises tetragonal and cubic phases. Also disclosed is a process for the production of a ceramic sintered shaped body containing Y.sub.2O.sub.3-stabilized zirconia, which process comprises dispersion of a submicron powder and comminution of the dispersed submicron powder by means of grinding media having a diameter of less than or equal to 100 μm to a particle size d.sub.95 of <0.42 μm; shaping of the dispersion to form a body, and sintering of the body to form the sintered shaped body.

A resorbable bone graft scaffold material, including a plurality of overlapping and interlocking fibers defining a scaffold structure, plurality of pores distributed throughout the scaffold, and a plurality of glass microspheres distributed throughout the pores. The fibers are characterized by fiber diameters ranging from about 5 nanometers to about 100 micrometers, and the fibers are a bioactive, resorbable material. The fibers generally contribute about 20 to about 40 weight percent of the scaffold material, with the microspheres contributing the balance.

A resorbable bone graft scaffold material, including a plurality of overlapping and interlocking fibers defining a scaffold structure, plurality of pores distributed throughout the scaffold, and a plurality of glass microspheres distributed throughout the pores. The fibers are characterized by fiber diameters ranging from about 5 nanometers to about 100 micrometers, and the fibers are a bioactive, resorbable material. The fibers generally contribute about 20 to about 40 weight percent of the scaffold material, with the microspheres contributing the balance.

Disclosed is a synthetic block intended for filling in a bone defect. The block is made up of a part made of ceramic material which has a shape that enables same to fill in the bone defect, and which is capable of being stabilized once placed in the bone defect, a three-dimensional network of channels communicating with one another being formed at least partially in the part such as to allow through the fluids and cells that enable revascularization with a view to cell growth once the part is in place in the bone defect, the channels opening onto each surface of the bone defect in contact with the part once it is placed in the bone defect.

Disclosed is a synthetic block intended for filling in a bone defect. The block is made up of a part made of ceramic material which has a shape that enables same to fill in the bone defect, and which is capable of being stabilized once placed in the bone defect, a three-dimensional network of channels communicating with one another being formed at least partially in the part such as to allow through the fluids and cells that enable revascularization with a view to cell growth once the part is in place in the bone defect, the channels opening onto each surface of the bone defect in contact with the part once it is placed in the bone defect.

Particular aspects of the present disclosure provide bio-resorbable and biocompatible compositions for bioengineering, restoring, or regenerating tissue or bone. In one embodiment, a biocompatible composition includes a three-dimensional porous or non-porous scaffold material comprising a calcium phosphate-based ceramic having at least one dopant therein selected from metal ion dopants or metal oxide dopants. The composition is sufficiently biocompatible to provide for a cell or tissue scaffold, and resorbable at a controlled resorption rate for controlled strength loss under body, body fluid or simulated body fluid conditions.

Particular aspects of the present disclosure provide bio-resorbable and biocompatible compositions for bioengineering, restoring, or regenerating tissue or bone. In one embodiment, a biocompatible composition includes a three-dimensional porous or non-porous scaffold material comprising a calcium phosphate-based ceramic having at least one dopant therein selected from metal ion dopants or metal oxide dopants. The composition is sufficiently biocompatible to provide for a cell or tissue scaffold, and resorbable at a controlled resorption rate for controlled strength loss under body, body fluid or simulated body fluid conditions.

The invention relates to a composition for the release of an active ingredient, comprising a porous matrix, a filled carrier in the matrix and the active ingredient in the carrier. The invention is suitable for the treatment of bone cancers.